Avalon Trust Co Has $376,000 Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Avalon Trust Co raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 29.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 721 shares of the medical equipment provider’s stock after buying an additional 166 shares during the quarter. Avalon Trust Co’s holdings in Intuitive Surgical were worth $376,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Atala Financial Inc acquired a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $25,000. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $26,000. BankPlus Trust Department acquired a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $28,000. Kohmann Bosshard Financial Services LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $31,000. Finally, MidAtlantic Capital Management Inc. acquired a new position in shares of Intuitive Surgical during the third quarter worth approximately $33,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $484.44 on Friday. The stock’s fifty day moving average is $567.46 and its 200-day moving average is $531.60. The stock has a market capitalization of $172.55 billion, a PE ratio of 75.58, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.

Insider Transactions at Intuitive Surgical

In other news, CFO Jamie Samath sold 94 shares of the stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This trade represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 33,754 shares of company stock worth $17,691,621. Insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of recent research reports. Truist Financial upped their target price on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Wells Fargo & Company upped their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Piper Sandler restated an “overweight” rating and issued a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. JPMorgan Chase & Co. upped their target price on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, Leerink Partners upped their target price on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.